MedTrace Logo

Effectiveness of Selling Micronutrient Sprinkles in Rural Kenya

NCT01088958 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 7200

Last updated 2015-07-30

No results posted yet for this study

Summary

The purpose of the study is to evaluate the effectiveness of household-based distribution of evidence-based health products and to measure the health impact of these combined interventions on a population basis.

Conditions

  • Anemia, Iron-deficiency

Interventions

DIETARY_SUPPLEMENT

Micronutrient powders (Sprinkles)

Sprinkles were developed in 1996 by Stanley Zlotkin's research group at the Hospital for Sick Children, University of Toronto as a novel approach for delivering iron and other micronutrients. They come in 1g sachets of dry powder that is then added to any home-prepared semi-solid food, intended for daily consumption by children aged 6-59 months. Formulation includes: Iron (Ferrous fumarate) 12.5 mg, Folic acid 150 µg, Vitamin A 375 µg, Vitamin C 35 mg, Zinc 5 mg, Vitamin B1 0.5 mg, Vitamin B2 0.5 mg, Vitamin B6 0.5 mg, Vitamin B12 0.9 µg, Vitamin D3 5 µg, Vitamin E 6.0 mg, Niacin 6.0 mg, Copper 0.6 mg, Iodine 50 µg

Sponsors & Collaborators

  • Safe Water and AIDS Project

    collaborator OTHER

  • Kenya Medical Research Institute

    collaborator OTHER

  • Global Alliance for Improved Nutrition

    collaborator OTHER

  • Centers for Disease Control and Prevention

    lead FED

Principal Investigators

  • Parminder S Suchdev, MD MPH · Centers for Disease Control and Prevention

Study Design

Allocation
RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
6 Months
Max Age
3 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2007-01-31
Primary Completion
2012-01-31
Completion
2014-09-30

Countries

  • Kenya

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01088958 on ClinicalTrials.gov